Abivax S.A.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +100.9% | -20.5% | -11.2% | +0.4% | -4.3% | +37.8% | +53.2% | -30.8% | +332.9% | -37.3% | +184.6% | |
| – | +665.1% | -35.5% | -25.0% | +0.5% | -13.0% | +106.5% | +99.7% | -51.9% | +690.4% | -40.3% | +222.8% | |
| – | +1,958.6% | -68.4% | -76.3% | +325.1% | +22.1% | +200.0% | +107.2% | -55.6% | +834.8% | -42.8% | +258.1% | |
| – | +1,238.3% | -41.3% | -25.9% | -23.7% | -24.9% | +199.9% | +107.2% | -55.6% | +868.4% | -44.7% | +267.6% | |
| – | +63.6% | +22.9% | -24.1% | +113.1% | -10.2% | +15.2% | +3.7% | -0.3% | +129.7% | -18.0% | -33.0% | |
| – | – | -55.6% | +282.7% | – | – | -2.5% | +256.2% | +204.7% | -148.3% | – | – | |
| – | – | – | – | – | – | -25.4% | +205.0% | +422.0% | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +2.3% | -43.8% | +0.0% | +0.0% | 0.0% | |
| – | -46.5% | – | – | – | – | +15.3% | -760.2% | – | 0.0% | +0.0% | -0.1% | |
| – | +11.6% | -13.8% | +45.2% | +244.2% | +70.9% | +61.1% | +56.0% | -17.9% | +91.7% | +25.6% | -21.6% | |
| – | +96.8% | -4.8% | +53.3% | +56.2% | +45.9% | +56.6% | +66.2% | +59.5% | +71.2% | +5.4% | -32.1% | |
| – | +31,900.0% | -20.3% | -33.3% | +6,311.8% | +90.3% | -99.9% | +85,166.7% | +193.5% | +4.1% | +40.0% | -32.8% | |
| – | +167.4% | -8.4% | +64.1% | +57.7% | +58.5% | +65.1% | +6.6% | -16.6% | +205.1% | -7.2% | -14.3% | |
| – | – | – | – | – | – | +37.1% | +87.9% | -31.6% | +22.2% | +16.7% | – | |
| – | +111.5% | -21.0% | -15.1% | -28.1% | -46.4% | -3.7% | +44.9% | -72.3% | +2,626.5% | -79.3% | +1,021.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.9% | +0.0% | +2.0% | +2.8% | +19.3% | +17.5% | +8.0% | +23.5% | +125.6% | +46.4% | +10.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.